PSA CONTROVERSY

The recent contradictory studies of more than 240,000 men published in the New England Journal of Medicine (NEJM) about the effectiveness of using the prostate specific antigen (PSA) test for reducing death from prostate cancer left many men and physicians confused, upset, disappointed, and wondering what they should now do. One study reported that PSA saves lives, while the other noted no benefit whatsoever.

To help our readers with this confusing data, we asked H. Ballentine Carter, M.D., Director of Adult Urology, and Patrick C. Walsh, M.D., University Distinguished Service Professor of Urology, to provides their thoughts.

Related Links

AUA Guidelines

American Cancer Society Guidelines

The Melbourne Consensus

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved. Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287

urology second opinion urology second opinion